国药现代(600420)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600420 国药现代

已收盘 07-17 15:00:00

{"stockData":{"symbol":"600420","market":"SH","secType":"STK","nameCN":"国药现代","latestPrice":12.36,"timestamp":1721199600000,"preClose":12.49,"halted":0,"volume":17683834,"delay":0,"floatShares":1341000000,"shares":1341000000,"eps":0.6293,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.13,"latestTime":"07-17 15:00:00","open":12.48,"high":12.66,"low":12.32,"amount":220000000,"amplitude":0.0272,"askPrice":12.36,"askSize":318,"bidPrice":12.35,"bidSize":204,"shortable":0,"etf":0,"ttmEps":0.6293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721266200000},"adr":0,"adjPreClose":12.49,"symbolType":"stock","openAndCloseTimeList":[[1721179800000,1721187000000],[1721192400000,1721199600000]],"highLimit":13.74,"lowLimit":11.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1341172692,"pbRate":1.3,"roa":"--","roe":"2.64%","epsLYR":0.5433,"committee":0.374335,"marketValue":16577000000,"floatMarketCap":16577000000,"peRate":19.640871,"changeRate":-0.0104,"turnoverRate":0.0132,"status":1},"requestUrl":"/m/hq/s/600420/wiki","defaultTab":"wiki","newsList":[{"id":"2452180187","title":"国药现代：高级管理人员龚忠退休离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2452180187","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452180187?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:46","pubTimestamp":1721206010,"startTime":"0","endTime":"0","summary":"每经AI快讯，国药现代 7月17日晚间发布公告称，龚忠先生由于到龄退休，申请辞去公司副总裁职务，辞职后，将不在公司担任其他任何职务。截至发稿，国药现代市值为166亿元。道达号“个股趋势”提醒：1. 国药现代近30日内北向资金持股量减少505.70万股，占流通股比例减少0.56%；2. 近30日内共有1批机构对国药现代调研，合计调研的机构家数为47家；3. 国药现代上一次发布人事变动公告是2024年03月30日，国药现代近一年共发布2次人事变动公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071716471095cd8fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071716471095cd8fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0239","BK0020","BK0010","BK0132","600420"],"gpt_icon":0},{"id":"2452072187","title":"国药现代最新公告：副总裁龚忠到龄退休 申请辞去公司副总裁职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2452072187","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452072187?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:40","pubTimestamp":1721205655,"startTime":"0","endTime":"0","summary":"国药现代公告，公司董事会近日收到公司副总裁龚忠的书面辞职申请。龚忠由于到龄退休，申请辞去公司副总裁职务，辞职后，将不在公司担任其他任何职务。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700033681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","600420","BK0020","BK0132","BK0082"],"gpt_icon":0},{"id":"2452818013","title":"国药现代：副总裁龚忠辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2452818013","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452818013?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:40","pubTimestamp":1721205649,"startTime":"0","endTime":"0","summary":"国药现代7月17日公告，公司董事会近日收到公司副总裁龚忠的书面辞职申请。龚忠由于到龄退休，申请辞去公司副总裁职务，辞职后，将不在公司担任其他任何职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717164049af92bca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717164049af92bca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0132","BK0010","BK0239","BK0020","600420","BK0082"],"gpt_icon":0},{"id":"2451600905","title":"【机构调研记录】鹏扬基金调研国药现代、太极股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2451600905","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451600905?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:02","pubTimestamp":1721088148,"startTime":"0","endTime":"0","summary":"2023年10月，公司中标国家税务总局专有云硬件资源更新采购项目，成交金额14588.82万元；公司以政务数据治理为基础，为教育、交通、医疗、工业等行业横向数据赋能鹏扬基金成立于2016年，截至目前，资产管理规模1088.37亿元，排名56/204；资产管理规模998.18亿元，排名47/204；管理公募基金数173只，排名34/204；旗下公募基金经理25人，排名51/204。旗下最近一年表现最佳的公募基金产品为鹏扬丰利一年定开债券A，最新单位净值为1.11，近一年增长6.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0188","BK0132","BK0030","BK0038","BK0231","BK0197","002368","BK0239","600420","BK0082","BK0058","BK0020"],"gpt_icon":0},{"id":"2451006186","title":"【机构调研记录】长盛基金调研盐津铺子、国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451006186","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451006186?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:02","pubTimestamp":1721088147,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月15日披露的机构调研信息，长盛基金近期对2家上市公司进行了调研，相关名单如下：1）盐津铺子 盐津铺子2024年一季报显示，公司主营收入12.23亿元，同比上升37.0%；归母净利润1.6亿元，同比上升43.1%；扣非净利润1.38亿元，同比上升40.08%；负债率46.12%，投资收益75.21万元，财务费用365.59万元，毛利率32.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002847","600420","BK0082","BK0132","BK0226","BK0239","BK0010","BK0020"],"gpt_icon":0},{"id":"2451600157","title":"【机构调研记录】平安基金调研中际旭创、国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451600157","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451600157?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088111,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为平安惠复纯债A，最新单位净值为1.1，近一年增长25.15%。旗下最新募集公募基金产品为平安惠嘉纯债A，类型为债券型-长债，集中认购期2024年5月28日至2024年8月27日。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","LU0039217434.USD","BK0077","HK0000306685.HKD","LU0871576103.HKD","SGXZ81163826.USD","LU0531971595.HKD","HK0000320264.USD","BK0167","600420","LU0164865239.USD","BK0082","HK0000320223.HKD","BK0028","LU1997245094.SGD","BK0132","300308","BK0239","SGXZ49509284.SGD","BK0020","BK0214","LU1655091616.SGD","BK0070","LU1770034418.SGD","HK0000306701.USD","LU1997245177.USD"],"gpt_icon":0},{"id":"2451009116","title":"【机构调研记录】安信基金调研国药现代、银轮股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2451009116","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451009116?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088106,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为安信丰泽39个月定开债，最新单位净值为1.01，近一年增长10.72%。旗下最新募集公募基金产品为安信远见稳进一年持有混合A，类型为混合型-偏股，集中认购期2024年6月3日至2024年7月17日。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0161","002126","600420","BK0264","BK0014","BK0082","BK0010","BK0020","BK0132"],"gpt_icon":0},{"id":"2451628600","title":"【机构调研记录】圆信永丰基金调研中际旭创、国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451628600","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451628600?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088103,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为圆信永丰聚兴一年定开债发起，最新单位净值为1.08，近一年增长10.25%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","SGXZ49509284.SGD","HK0000306701.USD","BK0020","LU0531971595.HKD","SGXZ81163826.USD","BK0077","HK0000320223.HKD","BK0132","LU0871576103.HKD","BK0167","BK0082","LU1997245177.USD","BK0010","BK0070","LU1655091616.SGD","HK0000306685.HKD","LU0039217434.USD","BK0214","600420","HK0000320264.USD","LU1997245094.SGD","BK0028","LU1770034418.SGD","300308","LU0164865239.USD"],"gpt_icon":0},{"id":"2451960090","title":"【机构调研记录】国泰基金调研国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451960090","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451960090?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088100,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为国泰中证沪港深动漫游戏ETF，最新单位净值为1.25，近一年增长44.54%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0020","BK0082","600420","BK0132","BK0239"],"gpt_icon":0},{"id":"2451006056","title":"【机构调研记录】国投瑞银基金调研中际旭创、国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451006056","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451006056?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088100,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为国投白银LOF，最新单位净值为0.99，近一年增长30.11%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","BK0082","SGXZ81163826.USD","HK0000306685.HKD","LU0164865239.USD","HK0000306701.USD","SGXZ49509284.SGD","BK0077","BK0070","LU0871576103.HKD","LU1655091616.SGD","HK0000320223.HKD","300308","BK0239","BK0028","LU1997245094.SGD","BK0167","600420","BK0010","BK0020","HK0000320264.USD","LU1997245177.USD","BK0132","LU1770034418.SGD","LU0039217434.USD","LU0531971595.HKD"],"gpt_icon":0},{"id":"2451006766","title":"【机构调研记录】华泰保兴基金调研国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451006766","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451006766?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088090,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为华泰保兴安悦债券A，最新单位净值为1.07，近一年增长8.76%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0010","BK0020","BK0132","BK0082","600420"],"gpt_icon":0},{"id":"2451997600","title":"【机构调研记录】光大保德信基金调研国药现代","url":"https://stock-news.laohu8.com/highlight/detail?id=2451997600","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451997600?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:01","pubTimestamp":1721088079,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为光大尊颐纯债一年债券发起，最新单位净值为1.07，近一年增长5.44%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600012676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0020","BK0082","BK0239","BK0132","600420"],"gpt_icon":0},{"id":"2451600576","title":"国药现代(600420.SH)：目前尚无实施股权激励的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2451600576","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451600576?lang=zh_cn&edition=full","pubTime":"2024-07-16 07:56","pubTimestamp":1721087789,"startTime":"0","endTime":"0","summary":"格隆汇7月16日丨国药现代(600420.SH)近日在接待机构投资者调研时表示，公司目前尚无实施股权激励的计划，后续如有安排会及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071607563595c3b699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071607563595c3b699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600420","BK0010","BK0082","BK0132","BK0239","BK0020"],"gpt_icon":0},{"id":"2451005796","title":"国药现代(600420.SH)：青霉素类、大环内酯类原料药市场需求依然比较旺盛","url":"https://stock-news.laohu8.com/highlight/detail?id=2451005796","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451005796?lang=zh_cn&edition=full","pubTime":"2024-07-16 07:55","pubTimestamp":1721087727,"startTime":"0","endTime":"0","summary":"格隆汇7月16日丨国药现代(600420.SH)近日在接待机构投资者调研时表示，首先，二季度公司业务发展基本延续了一季度的经营形势。青霉素类、大环内酯类原料药市场需求依然比较旺盛。公司充分利用产业链优势，积极把握市场机遇，调整产品结构，提高了高毛利产品的生产销售占比。其次，公司持续强化预算管理，严格费用管控，期间费用特别是销售费用同比下降明显。再次，公司持续开展提质增效专项工作，通过改进工艺技术、强化一体化管理、规模化生产等方式，加强成本管控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160755349f523474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160755349f523474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0082","BK0020","BK0010","600420","BK0132"],"gpt_icon":0},{"id":"2451171746","title":"国药现代：7月9日接受机构调研，兴业证券、招商基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2451171746","media":"证星公司调研","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451171746?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:24","pubTimestamp":1721039040,"startTime":"0","endTime":"0","summary":"股东大会授权董事会，于2024年半年度结合未分配利润与当期业绩，制定具体的2024年中期分红方案，并将在规定期限内实施。国药现代主营业务：医药产品研发、生产与销售。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151826209f4e5b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151826209f4e5b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","601377","BK0132","BK0239","600420","BK0188","BK0012","BK0082","BK0183","BK0020","BK0276","BK0010"],"gpt_icon":0},{"id":"2451611573","title":"国药现代：子公司阿莫西林克拉维酸钾片通过一致性评价 有利于该产品未来市场拓展和销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2451611573","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451611573?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:29","pubTimestamp":1721035776,"startTime":"0","endTime":"0","summary":"中国财富通7月15日 - 国药现代（600420）公告称，近日，公司全资子公司国药集团威奇达药业有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准阿莫西林克拉维酸钾片通过仿制药质量和疗效一致性评价。国药威奇达阿莫西林克拉维酸钾片通过一致性评价将有利于该产品未来的市场拓展和销售。上述事项对公司目前经营业绩不会产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=WMLCjRo3HK0%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0239","600420","BK0082","BK0020","BK0010"],"gpt_icon":0},{"id":"2451261982","title":"国药现代最新公告：子公司药品通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2451261982","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451261982?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:10","pubTimestamp":1721034615,"startTime":"0","endTime":"0","summary":"国药现代公告，子公司国药威奇达的阿莫西林克拉维酸钾片通过仿制药质量和疗效一致性评价。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500023041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","600420","BK0010","BK0239","BK0132","BK0082"],"gpt_icon":0},{"id":"2451165496","title":"国药现代(600420.SH)：阿莫西林克拉维酸钾片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2451165496","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451165496?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:01","pubTimestamp":1721034075,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药现代 公告，公司全资子公司国药集团威奇达药业有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准阿莫西林克拉维酸钾片通过仿制药质量和疗效一致性评价。公告显示，阿莫西林克拉维酸钾片的活性成分为阿莫西林、克拉维酸，阿莫西林为广谱青霉素类抗生素，克拉维酸钾本身只有微弱的抗菌活性，但具有强大的广谱β-内酰胺酶抑制作用，两者合用，可保护阿莫西林免遭β-内酰胺酶水解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0020","BK0010","BK0239","BK0082","600420","BK0132"],"gpt_icon":0},{"id":"2450442879","title":"北向资金7月10日净卖出国药现代160.75万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450442879","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450442879?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:30","pubTimestamp":1720661413,"startTime":"0","endTime":"0","summary":"7月10日，北向资金减持国药现代160.75万股连续3日减持。截止当日收盘，沪股通共持有国药现代1560.96万股，占流通股1.30%。沪股通减持金额前五个股分别为赛力斯、北汽蓝谷、中国石化、中国铝业、伊利股份。国药现代近5个交易日上涨11.17%，沪股通累计减持112.67万股；近20个交易日上涨7.83%，沪股通累计减持451.14万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110931159f3103a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110931159f3103a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0010","BK0239","BK0132","600420","BK0020"],"gpt_icon":0},{"id":"2450262878","title":"28.51亿元市值限售股今日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2450262878","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450262878?lang=zh_cn&edition=full","pubTime":"2024-07-11 08:19","pubTimestamp":1720657188,"startTime":"0","endTime":"0","summary":"Wind数据显示，周四（7月11日），共有11家公司限售股解禁，合计解禁量为2.53亿股，按最新收盘价计算，合计解禁市值为28.51亿元。从解禁量来看，2家公司解禁股数超千万股。国药现代、中国核建、美的集团解禁量居前，解禁股数分别为1.45亿股、8888.89万股、461.49万股。从解禁市值来看，2家公司解禁股数超亿元。国药现代、中国核建、美的集团解禁市值居前，解禁市值分别为17.18亿元、6.91亿元、2.94亿元。从解禁股数占总股本比例来看，1家公司解禁比例超10%。国药现代、中国核建、东亚机械解禁比例居前，解禁比例分别为10.82%、2.95%、0.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711081948af91acf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711081948af91acf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0132","601611","600420","BK0239","BK0082","BK0020","BK0010"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2004-06-16","address":"上海市浦东新区建陆路378号","stockEarnings":[{"period":"1week","weight":0.0675},{"period":"1month","weight":0.1534},{"period":"3month","weight":0.2707},{"period":"6month","weight":0.396},{"period":"1year","weight":0.1673},{"period":"ytd","weight":0.2876}],"companyName":"上海现代制药股份有限公司","boardCode":"AI0027","perCapita":"37283股","boardName":"医药制造业","registeredCapital":"134117万元","compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.031},{"period":"6month","weight":0.0459},{"period":"1year","weight":-0.0727},{"period":"ytd","weight":0.0005}],"survey":"　　上海现代制药股份有限公司主营业务是医药产品研发、生产与销售。全身用抗感染、心血管、抗肿瘤及免疫调节剂、中枢神经系统、激素、泌尿生殖系统、消化道和新陈代谢、呼吸系统等治疗领域公司多个产品荣获国家及省市级重点新产品奖，具有较高的市场占有率和品牌知名度。根据中国医药健康信息平台——米内网发起主办的“中国医药工业百强系列榜单”，公司位列2022年度“中国化药企业TOP100排行榜”第13名。","serverTime":1721215966000,"listedPrice":8.08,"stockholders":"35972人(较上一季度增加3.20%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药现代(600420)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药现代(600420)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药现代,600420,国药现代股票,国药现代股票老虎,国药现代股票老虎国际,国药现代行情,国药现代股票行情,国药现代股价,国药现代股市,国药现代股票价格,国药现代股票交易,国药现代股票购买,国药现代股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药现代(600420)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药现代(600420)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}